Joyce Lee – General Manager, Amgen Taiwan
Joyce Lee, general manager of Amgen Taiwan, shares her journey of building up the affiliate after only having entered the market three years ago and goes on to offer insights…
Address:
Tel: 886-2-2655-8133
In view of the need for an inter-agency task to carry out the promotion of the biotechnology and pharmaceutical high-tech industries, in November 1995 the Executive Yuan approved the key points for establishing the Biotechnology and Pharmaceutical Industries Program Office (BPIPO, MOEA). In February 1996 the BPIPO was formerly established to implement and promote the biotechnology industry’s development policy and act as a bridge for communication, coordination and integration among agencies. In December 2001, The Executive Yuan’s One-Stop-Service Office for the Biotechnology Industry was established under the BPIPO, with the office being responsible for the integration and coordination of local organizations involved in the various biotech-related approval and application processes, to build up a sound development environment for the biotech industry. The Director of the Industrial Development Bureau, MOEA acted as convener of the Program Office and formed a committee including the heads of the Executive Yuan’s Department of Health; Environmental Protection Administration; Council for Economic Planning and Development; National Science Council; Council of Agriculture; Science & Technology Advisory Group (STAG); Committee for the Development Fund; Department of Industrial Technology, MOEA; Intellectual Property Office, MOEA; and related government agencies; and representatives, academics, and experts from major research organizations and industry to form an inter-agency promotional organization.
The role of the Program Office is to serve as a window for the exchange of vital information between domestic and foreign industry, and to aggressively promote investment in Taiwan. In so doing, the Program Office hopes to accelerate the upgrading of Taiwan’s biotechnology and pharmaceutical industries and promote Taiwan to become an R&D, manufacturing and operations center for the Asia Pacific region, and furthermore to forge ahead to establish a global operations center.
Joyce Lee, general manager of Amgen Taiwan, shares her journey of building up the affiliate after only having entered the market three years ago and goes on to offer insights…
Dr. Wen-cherng Tsai, founder and chairman of SuperLab, explains the company’s unique business model as the only third-party fair testing organization and pre-clinical CRO across the medical, chemical and biological…
Michelle Lin, CEO, and Hsu Chang, Senior Advisor of EpiSonica, highlight the innovative new solutions that the company has created for women’s health and medical imagining. The advanced technology will…
Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in…
Dr Hardy Chan shares the story of how he came out of retirement to lead Allianz Pharmascience; an up-and-coming biotech which aims to meet the unmet medical needs of rare…
Grace Yang, general manager of TSH Biopharm, discusses how the company is uniquely positioned to deliver end-to-end healthcare solutions to the APAC region in the areas of cardiovascular, gastrointestinal, autoimmune,…
Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s adoption of the emerging field. In order to…
Eric Yang, secretary general of the Taiwan Precision Medical and Molecular Diagnostics Industry Association (PMMD), speaks about the key challenges facing the sector and the top priorities of the organization…
Taiwan has long been a leader in biotechnology research and development. With the government’s emphasis on higher education and research, Taiwan has trained a diverse pool of talent in the…
Dr Mien-Chie Hung, president of China Medical University, shares his personal mission upon taking the role only three months ago. Dr Hung also elaborates on the research strengths of CMU…
Pei-Li Li, CSO and executive VP of VtR Inc, expands on the company’s unique positioning and expertise as one of the few local teams in the greater China area that…
Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination. Over…
See our Cookie Privacy Policy Here
